ARTICLE | Company News
La Jolla Pharma other research news
August 13, 2001 7:00 AM UTC
LJPC said an analysis of serum samples from 106 APS patients published in Thrombosis and Haemostasis confirmed that a binding site recognized by anti-b2-GPI antibodies on platelets is responsible for ...